Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Sherie Morrison

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Concepts & Ideas

Molecular Sequence Data

Physiology

Transfection

Genes & Molecular Sequences

Anatomy

Cell Line

Phenomena

Glycosylation

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
23
Penichet, Manuel
16
Wims, Letitia
15
Shin, Seung-Uon
13
Chintalacharuvu, Koteswara
10
Dela Cruz, Jay
10
Coloma, MJ
8
Trinh, Ryan
6
Harvill, Eric
5
Rosenblatt, Joseph
5
Trinh, Ryan
5
Yoo, Esther
4
Pardridge, William
4
Ng, Patrick
4
Gurbaxani, Brian
4
Bonagura, Vincent

Sign-in to see all Coauthors

Publications

TOP 3
Cho John S; Hsu Jeffrey V; Morrison Sherie L
Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunity.
Afshar Sepideh; Sawaya Michael R; Morrison Sherie L
Structure of a mutant human purine nucleoside phosphorylase with the prodrug, 2-fluoro-2'-deoxyadenosine and the cytotoxic drug, 2-fluoroadenine.
Mershon Kileen L; Vasuthasawat Alex; Lawson Gregory W; Morrison Sherie L; Beenhouwer David O
Role of complement in protection against Cryptococcus gattii infection.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Sherie Morrison (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Cho John S; Hsu Jeffrey V; Morrison Sherie L
Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunity.
Cancer immunology, immunotherapy : CII 2009;58(7):1057-69.
2009: Afshar Sepideh; Sawaya Michael R; Morrison Sherie L
Structure of a mutant human purine nucleoside phosphorylase with the prodrug, 2-fluoro-2'-deoxyadenosine and the cytotoxic drug, 2-fluoroadenine.
Protein science : a publication of the Protein Society 2009;18(5):1107-14.
2009: Mershon Kileen L; Vasuthasawat Alex; Lawson Gregory W; Morrison Sherie L; Beenhouwer David O
Role of complement in protection against Cryptococcus gattii infection.
Infection and immunity 2009;77(3):1061-70.
2009: Afshar Sepideh; Asai Tsuneaki; Morrison Sherie L
Humanized ADEPT comprised of an engineered human purine nucleoside phosphorylase and a tumor targeting peptide for treatment of cancer.
Molecular cancer therapeutics 2009;8(1):185-93.
2009: Cho John S; Kim Yun C; Morrison Sherie L
Inhibitors of MyD88-dependent proinflammatory cytokine production identified utilizing a novel RNA interference screening approach.
PloS one 2009;4(9):e7029.
2009: Kim Yun Cheol; Morrison Sherie L
N-terminal domain-deleted mu transposase exhibits increased transposition activity with low target site preference in modified buffers.
Journal of molecular microbiology and biotechnology 2009;17(1):30-40.
2008: Cheng Lucy S; Hwang Seungmin; Huang Tzu-Hsuan; Sheu Ting-Chang; Sun Ren; Morrison Sherie L; Cheng Genhong; Shahangian Arash
Antibody-fused interferons as an effective approach to enhance target specificity and antiviral efficacy of type I interferons.
Cell research 2008;18(12):1230-2.
2008: Aslam Akhmed; Quinn Phyllis; McIntosh Richard S; Shi Jianguo; Ghumra Ashfaq; McKerrow James H; Bunting Karen A; Dunne David W; Doenhoff Michael J; Morrison Sherie L; Zhang Ke; Pleass Richard J
Proteases from Schistosoma mansoni cercariae cleave IgE at solvent exposed interdomain regions.
Molecular immunology 2008;45(2):567-74.
2007: Morrison Sherie L
Two heads are better than one.
Nature biotechnology 2007;25(11):1233-4.
2007: Huang Tzu-Hsuan; Chintalacharuvu Koteswara R; Morrison Sherie L
Targeting IFN-alpha to B cell lymphoma by a tumor-specific antibody elicits potent antitumor activities.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(10):6881-8.
2007: Chintalacharuvu Koteswara R; Gurbaxani Brian; Morrison Sherie L
Incomplete assembly of IgA2m(2) in Chinese hamster ovary cells.
Molecular immunology 2007;44(13):3445-52.
2007: Olafsen Tove; Gu Zhennan; Sherman Mark A; Leyton Jeffrey V; Witkosky Michael E; Shively John E; Raubitschek Andrew A; Morrison Sherie L; Wu Anna M; Reiter Robert E
Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2007;30(4):396-405.
2007: Beenhouwer David O; Yoo Esther M; Lai Chun-Wei; Rocha Miguel A; Morrison Sherie L
Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.
Infection and immunity 2007;75(3):1424-35.
2006: Ng Patrick P; Helguera Gustavo; Daniels Tracy R; Lomas Simon Z; Rodriguez Jose A; Schiller Gary; Bonavida Benjamin; Morrison Sherie L; Penichet Manuel L
Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.
Blood 2006;108(8):2745-54.
2006: Samuelsson Martin; Jendholm Johan; Amisten Stefan; Morrison Sherie L; Forsgren Arne; Riesbeck Kristian
The IgD CH1 region contains the binding site for the human respiratory pathogen Moraxella catarrhalis IgD-binding protein MID.
European journal of immunology 2006;36(9):2525-34.
2006: Huang Tzu-Hsuan; Morrison Sherie L
A trimeric anti-HER2/neu ScFv and tumor necrosis factor-alpha fusion protein induces HER2/neu signaling and facilitates repair of injured epithelia.
The Journal of pharmacology and experimental therapeutics 2006;316(3):983-91.
2006: Gurbaxani Brian Mohan; Morrison Sherie L
Development of new models for the analysis of Fc-FcRn interactions.
Molecular immunology 2006;43(9):1379-89.
2006: Gurbaxani Brian; Dela Cruz Linh L; Chintalacharuvu Koteswara; Morrison Sherie L
Analysis of a family of antibodies with different half-lives in mice fails to find a correlation between affinity for FcRn and serum half-life.
Molecular immunology 2006;43(9):1462-73.
2006: Dela Cruz Jay Soriano; Trinh Kamh Ryan; Chen Hsiao Wen; Ribas Antoni; Morrison Sherie L; Penichet Manuel L
Anti-HER2/neu IgG3-(IL-2) and anti-HER2/neu IgG3-(GM-CSF) promote HER2/neu processing and presentation by dendritic cells: implications in immunotherapy and vaccination strategies.
Molecular immunology 2006;43(6):667-76.
2006: Helguera Gustavo; Dela Cruz Jay S; Lowe Christine; Ng Patrick P; Trinh Ryan; Morrison Sherie L; Penichet Manuel L
Vaccination with novel combinations of anti-HER2/neu cytokines fusion proteins and soluble protein antigen elicits a protective immune response against HER2/neu expressing tumors.
Vaccine 2006;24(3):304-16.
2005: Zhu Lei; van de Lavoir Marie-Cecile; Albanese Jenny; Beenhouwer David O; Cardarelli Pina M; Cuison Severino; Deng David F; Deshpande Shrikant; Diamond Jennifer H; Green Lynae; Halk Edward L; Heyer Babette S; Kay Robert M; Kerchner Allyn; Leighton Philip A; Mather Christine M; Morrison Sherie L; Nikolov Zivko L; Passmore David B; Pradas-Monne Alicia; Preston Benjamin T; Rangan Vangipuram S; Shi Mingxia; Srinivasan Mohan; White Steven G; Winters-Digiacinto Peggy; Wong Susan; Zhou Wen; Etches Robert J
Production of human monoclonal antibody in eggs of chimeric chickens.
Nature biotechnology 2005;23(9):1159-69.
2005: Dela Cruz Jay S; Morrison Sherie L; Penichet Manuel L
Insights into the mechanism of anti-tumor immunity in mice vaccinated with the human HER2/neu extracellular domain plus anti-HER2/neu IgG3-(IL-2) or anti-HER2/neu IgG3-(GM-CSF) fusion protein.
Vaccine 2005;23(39):4793-803.
2005: Yoo Esther M; Morrison Sherie L
IgA: an immune glycoprotein.
Clinical immunology (Orlando, Fla.) 2005;116(1):3-10.
2005: Cho Hyun-Mi; Rosenblatt Joseph D; Kang Young-Sook; Iruela-Arispe M Luisa; Morrison Sherie L; Penichet Manuel L; Kwon Young-Guen; Kim Tae-Woong; Webster Keith A; Nechustan Hovav; Shin Seung-Uon
Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein.
Molecular cancer therapeutics 2005;4(6):956-67.
2005: Asai Tsuneaki; Wims Letitia A; Morrison Sherie L
An interaction between S*tag and S*protein derived from human ribonuclease 1 allows site-specific conjugation of an enzyme to an antibody for targeted drug delivery.
Journal of immunological methods 2005;299(1-2):63-76.
2005: Asai Tsuneaki; Trinh Ryan; Ng Patrick P; Penichet Manuel L; Wims Letitia A; Morrison Sherie L
A human biotin acceptor domain allows site-specific conjugation of an enzyme to an antibody-avidin fusion protein for targeted drug delivery.
Biomolecular engineering 2005;21(6):145-55.
2004: Dela Cruz J S; Huang T H; Penichet M L; Morrison S L
Antibody-cytokine fusion proteins: innovative weapons in the war against cancer.
Clinical and experimental medicine 2004;4(2):57-64.
2004: Chan Lisa A; Phillips Martin L; Wims Letitia A; Trinh K Ryan; Denham Jerrod; Morrison Sherie L
Variable region domain exchange in human IgGs promotes antibody complex formation with accompanying structural changes and altered effector functions.
Molecular immunology 2004;41(5):527-38.
2004: Gala Françoise A; Morrison Sherie L
V region carbohydrate and antibody expression.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(9):5489-94.
2004: Trinh Ryan; Gurbaxani Brian; Morrison Sherie L; Seyfzadeh Manouchehr
Optimization of codon pair use within the (GGGGS)3 linker sequence results in enhanced protein expression.
Molecular immunology 2004;40(10):717-22.
2003: Roque-Navarro Lourdes; Mateo Cristina; Lombardero Josefa; Mustelier Geraudis; Fernández Alicia; Sosa Katya; Morrison Sherrie L; Pérez Rolando
Humanization of predicted T-cell epitopes reduces the immunogenicity of chimeric antibodies: new evidence supporting a simple method.
Hybridoma and hybridomics 2003;22(4):245-57.
2003: Chintalacharuvu Koteswara R; Chuang Philip D; Dragoman Ashley; Fernandez Christine Z; Qiu Jiazhou; Plaut Andrew G; Trinh K Ryan; Gala Françoise A; Morrison Sherie L
Cleavage of the human immunoglobulin A1 (IgA1) hinge region by IgA1 proteases requires structures in the Fc region of IgA.
Infection and immunity 2003;71(5):2563-70.
2003: Yoo Esther M; Wims Letitia A; Chan Lisa A; Morrison Sherie L
Human IgG2 can form covalent dimers.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(6):3134-8.
2003: Dela Cruz Jay S; Lau Suk Ying; Ramirez Ernesto M; De Giovanni Carla; Forni Guido; Morrison Sherie L; Penichet Manuel L
Protein vaccination with the HER2/neu extracellular domain plus anti-HER2/neu antibody-cytokine fusion proteins induces a protective anti-HER2/neu immune response in mice.
Vaccine 2003;21(13-14):1317-26.
2002: Helguera G; Morrison S L; Penichet M L
Antibody-cytokine fusion proteins: harnessing the combined power of cytokines and antibodies for cancer therapy.
Clinical immunology (Orlando, Fla.) 2002;105(3):233-46.
2002: Chintalacharuvu Koteswara R; Yu Li J; Bhola Nishant; Kobayashi Kunihiko; Fernandez Christine Z; Morrison Sherie L
Cysteine residues required for the attachment of the light chain in human IgA2.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(9):5072-7.
2002: Ng Patrick P; Dela Cruz Jay S; Sorour David N; Stinebaugh James M; Shin Seung-Uon; Shin Daniel S; Morrison Sherie L; Penichet Manuel L
An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(16):10706-11.
2002: Gala Francoise A; Morrison Sherie L
The role of constant region carbohydrate in the assembly and secretion of human IgD and IgA1.
The Journal of biological chemistry 2002;277(32):29005-11.
2002: Morrison Sherie L
Cloning, expression, and modification of antibody V regions.
Current protocols in immunology / edited by John E. Coligan ... [et al.] 2002;Chapter 2():Unit 2.12.
2002: Yoo Esther M; Chintalacharuvu Koteswara R; Penichet Manuel L; Morrison Sherie L
Myeloma expression systems.
Journal of immunological methods 2002;261(1-2):1-20.
2002: Morrison Sherie L; Mohammed Mansoor S; Wims Letitia A; Trinh Ryan; Etches Robert
Sequences in antibody molecules important for receptor-mediated transport into the chicken egg yolk.
Molecular immunology 2002;38(8):619-25.
2002: Montaño Ramon F; Morrison Sherie L
Influence of the isotype of the light chain on the properties of IgG.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(1):224-31.
2001: Chintalacharuvu K R; Vuong L U; Loi L A; Larrick J W; Morrison S L
Hybrid IgA2/IgG1 antibodies with tailor-made effector functions.
Clinical immunology (Orlando, Fla.) 2001;101(1):21-31.
2001: Peng L S; Penichet M L; Dela Cruz J S; Sampogna S L; Morrison S L
Mechanism of antitumor activity of a single-chain interleukin-12 IgG3 antibody fusion protein (mscIL-12.her2.IgG3).
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2001;21(9):709-20.
2001: Morrison S L
Double-stranded DNA sequence analysis.
Current protocols in immunology / edited by John E. Coligan ... [et al.] 2001;Chapter 10():Unit 10.25.
2001: Morrison S L
Transfection of lymphoid cells.
Current protocols in immunology / edited by John E. Coligan ... [et al.] 2001;Chapter 10():Unit 10.17B.
2001: Morrison S L
Transformation of E. coli by electroporation.
Current protocols in immunology / edited by John E. Coligan ... [et al.] 2001;Appendix 3():Appendix 3N.
2001: Morrison S L
Preparing frozen bacterial stocks.
Current protocols in immunology / edited by John E. Coligan ... [et al.] 2001;Appendix 3():Appendix 3M.
2001: Penichet M L; Dela Cruz J S; Challita-Eid P M; Rosenblatt J D; Morrison S L
A murine B cell lymphoma expressing human HER2 / neu undergoes spontaneous tumor regression and elicits antitumor immunity.
Cancer immunology, immunotherapy : CII 2001;49(12):649-62.
2001: Penichet M L; Morrison S L
Antibody-cytokine fusion proteins for the therapy of cancer.
Journal of immunological methods 2001;248(1-2):91-101.
2001: Penichet M L; Dela Cruz J S; Shin S U; Morrison S L
A recombinant IgG3-(IL-2) fusion protein for the treatment of human HER2/neu expressing tumors.
Human antibodies 2001;10(1):43-9.
2000: Coloma M J; Clift A; Wims L; Morrison S L
The role of carbohydrate in the assembly and function of polymeric IgG.
Molecular immunology 2000;37(18):1081-90.
2000: Mateo C; Lombardero J; Moreno E; Morales A; Bombino G; Coloma J; Wims L; Morrison S L; Pérez R
Removal of amphipathic epitopes from genetically engineered antibodies: production of modified immunoglobulins with reduced immunogenicity.
Hybridoma 2000;19(6):463-71.
2000: Dela Cruz J S; Trinh K R; Morrison S L; Penichet M L
Recombinant anti-human HER2/neu IgG3-(GM-CSF) fusion protein retains antigen specificity and cytokine function and demonstrates antitumor activity.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(9):5112-21.
2000: Trinh K R; Morrison S L
Site-specific and directional gene replacement mediated by Cre recombinase.
Journal of immunological methods 2000;244(1-2):185-93.
2000: Rifai A; Fadden K; Morrison S L; Chintalacharuvu K R
The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes.
The Journal of experimental medicine 2000;191(12):2171-82.
2000: Chan L A; Lyczak J B; Zhang K; Morrison S L; Saxon A
The novel human IgE epsilon heavy chain, epsilon tailpiece, is present in plasma as part of a covalent complex.
Molecular immunology 2000;37(5):241-52.
2000: Coloma M J; Lee H J; Kurihara A; Landaw E M; Boado R J; Morrison S L; Pardridge W M
Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor.
Pharmaceutical research 2000;17(3):266-74.
1999: Yoo E M; Coloma M J; Trinh K R; Nguyen T Q; Vuong L U; Morrison S L; Chintalacharuvu K R
Structural requirements for polymeric immunoglobulin assembly and association with J chain.
The Journal of biological chemistry 1999;274(47):33771-7.
1999: Penichet M L; Kang Y S; Pardridge W M; Morrison S L; Shin S U
An antibody-avidin fusion protein specific for the transferrin receptor serves as a delivery vehicle for effective brain targeting: initial applications in anti-HIV antisense drug delivery to the brain.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(8):4421-6.
1999: Peng L S; Penichet M L; Morrison S L
A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activity.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(1):250-8.
1999: Penichet M L; Challita P M; Shin S U; Sampogna S L; Rosenblatt J D; Morrison S L
In vivo properties of three human HER2/neu-expressing murine cell lines in immunocompetent mice.
Laboratory animal science 1999;49(2):179-88.
1999: Chintalacharuvu K R; Morrison S L
Production and characterization of recombinant IgA.
Immunotechnology : an international journal of immunological engineering 1999;4(3-4):165-74.
1999: Coloma M J; Trinh R K; Martinez A R; Morrison S L
Position effects of variable region carbohydrate on the affinity and in vivo behavior of an anti-(1-->6) dextran antibody.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(4):2162-70.
1999: Montaño R F; Morrison S L
A colorimetric-enzymatic microassay for the quantitation of antibody-dependent complement activation.
Journal of immunological methods 1999;222(1-2):73-82.
1998: Guan L; Wims L A; Kane R R; Smuckler M B; Morrison S L; Hawthorne M F
Homogeneous immunoconjugates for boron neutron-capture therapy: design, synthesis, and preliminary characterization.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(22):13206-10.
1998: Challita-Eid P M; Abboud C N; Morrison S L; Penichet M L; Rosell K E; Poles T; Hilchey S P; Planelles V; Rosenblatt J D
A RANTES-antibody fusion protein retains antigen specificity and chemokine function.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(7):3729-36.
1998: Penichet M L; Harvill E T; Morrison S L
An IgG3-IL-2 fusion protein recognizing a murine B cell lymphoma exhibits effective tumor imaging and antitumor activity.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1998;18(8):597-607.
1998: Challita-Eid P M; Penichet M L; Shin S U; Poles T; Mosammaparast N; Mahmood K; Slamon D J; Morrison S L; Rosenblatt J D
A B7.1-antibody fusion protein retains antibody specificity and ability to activate via the T cell costimulatory pathway.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(7):3419-26.
1998: Wright A; Morrison S L
Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(7):3393-402.
1998: Morrison S L; Porter S B; Trinh K R; Wims L A; Denham J; Oi V T
Variable region domain exchange influences the functional properties of IgG.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(6):2802-8.
1997: Sensel M G; Kane L M; Morrison S L
Amino acid differences in the N-terminus of C(H)2 influence the relative abilities of IgG2 and IgG3 to activate complement.
Molecular immunology 1997;34(14):1019-29.
1997: Chintalacharuvu K R; Morrison S L
Production of secretory immunoglobulin A by a single mammalian cell.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(12):6364-8.
1997: Shin S U; Wu D; Ramanathan R; Pardridge W M; Morrison S L
Functional and pharmacokinetic properties of antibody-avidin fusion proteins.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(10):4797-804.
1997: Coloma M J; Morrison S L
Design and production of novel tetravalent bispecific antibodies.
Nature biotechnology 1997;15(2):159-63.
1997: McGrath J P; Cao X; Schutz A; Lynch P; Ebendal T; Coloma M J; Morrison S L; Putney S D
Bifunctional fusion between nerve growth factor and a transferrin receptor antibody.
Journal of neuroscience research 1997;47(2):123-33.
1997: Coloma M J; Trinh K R; Wims L A; Morrison S L
The hinge as a spacer contributes to covalent assembly and is required for function of IgG.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(2):733-40.
1997: Chuang P D; Morrison S L
Elimination of N-linked glycosylation sites from the human IgA1 constant region: effects on structure and function.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(2):724-32.
1997: Penichet M L; Harvill E T; Morrison S L
Antibody-IL-2 fusion proteins: a novel strategy for immune protection.
Human antibodies 1997;8(3):106-18.
1997: Sensel M G; Coloma M J; Harvill E T; Shin S U; Smith R I; Morrison S L
Engineering novel antibody molecules.
Chemical immunology 1997;65():129-58.
1996: Chintalacharuvu K R; Morrison S L
Residues critical for H-L disulfide bond formation in human IgA1 and IgA2.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(8):3443-9.
1996: Harvill E T; Fleming J M; Morrison S L
In vivo properties of an IgG3-IL-2 fusion protein. A general strategy for immune potentiation.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(7):3165-70.
1996: Harvill E T; Morrison S L
An IgG3-IL-2 fusion protein has higher affinity than hrIL-2 for the IL-2R alpha subunit: real time measurement of ligand binding.
Molecular immunology 1996;33(11-12):1007-14.
1996: LaVallee T M; Morrison S L
Identification and functional characterization of a highly conserved sequence in the intron of the kappa light chain gene.
Molecular immunology 1996;33(11-12):973-88.
1996: Lyczak J B; Zhang K; Saxon A; Morrison S L
Expression of novel secreted isoforms of human immunoglobulin E proteins.
The Journal of biological chemistry 1996;271(7):3428-36.
1995: Harvill E T; Morrison S L
An IgG3-IL2 fusion protein activates complement, binds Fc gamma RI, generates LAK activity and shows enhanced binding to the high affinity IL-2R.
Immunotechnology : an international journal of immunological engineering 1995;1(2):95-105.
1995: Poon P H; Morrison S L; Schumaker V N
Structure and function of several anti-dansyl chimeric antibodies formed by domain interchanges between human IgM and mouse IgG2b.
The Journal of biological chemistry 1995;270(15):8571-7.
1995: Smith R I; Coloma M J; Morrison S L
Addition of a mu-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(5):2226-36.
1995: Shin S U; Friden P; Moran M; Olson T; Kang Y S; Pardridge W M; Morrison S L
Transferrin-antibody fusion proteins are effective in brain targeting.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(7):2820-4.
1994: Wright A; Morrison S L
Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.
The Journal of experimental medicine 1994;180(3):1087-96.
1994: Smith R I; Morrison S L
Recombinant polymeric IgG: an approach to engineering more potent antibodies.
Bio/technology (Nature Publishing Company) 1994;12(7):683-8.
1994: Chintalacharuvu K R; Raines M; Morrison S L
Divergence of human alpha-chain constant region gene sequences. A novel recombinant alpha 2 gene.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(11):5299-304.
1994: Chou C L; Morrison S L
Intron sequences determine the expression of kappa light chain genes.
Molecular immunology 1994;31(2):99-107.
1994: Shin S U; Friden P; Moran M; Morrison S L
Functional properties of antibody insulin-like growth factor fusion proteins.
The Journal of biological chemistry 1994;269(7):4979-85.
1994: Lyczak J B; Morrison S L
Biological and pharmacokinetic properties of a novel immunoglobulin-CD4 fusion protein.
Archives of virology 1994;139(1-2):189-96.
1994: Kanda S; Takeyama H; Kikumoto Y; Morrison S L; Morton D L; Irie R F
Both VH and VL regions contribute to the antigenicity of anti-idiotypic antibody that mimics melanoma associated ganglioside GM3.
Cell biophysics 1994;24-25():65-74.
1993: Bonagura V R; Artandi S E; Davidson A; Randen I; Agostino N; Thompson K; Natvig J B; Morrison S L
Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis-derived monoclonal rheumatoid factors.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(7):3840-52.
1993: Tao M H; Smith R I; Morrison S L
Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation.
The Journal of experimental medicine 1993;178(2):661-7.
1993: Chou C L; Morrison S L
A common sequence motif near nonhomologous recombination breakpoints involving Ig sequences.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(12):5350-60.
1993: Chou C L; Morrison S L
An insertion-deletion event in murine immunoglobulin kappa gene resembles mutations at heavy-chain disease loci.
Somatic cell and molecular genetics 1993;19(2):131-9.
1993: Shin S U; Wright A; Morrison S L
Hybrid antibodies.
International reviews of immunology 1993;10(2-3):177-86.
1993: Wright A; Morrison S L
Antibody variable region glycosylation: biochemical and clinical effects.
Springer seminars in immunopathology 1993;15(2-3):259-73.
1992: Shin S U; Wright A; Bonagura V; Morrison S L
Genetically-engineered antibodies: tools for the study of diverse properties of the antibody molecule.
Immunological reviews 1992;130():87-107.
1992: Braun J; Saxon A; Wall R; Morrison S L
The second century of the antibody. Molecular perspectives in regulation, pathophysiology, and therapeutic applications.
The Western journal of medicine 1992;157(2):158-68.
1992: Coloma M J; Hastings A; Wims L A; Morrison S L
Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction.
Journal of immunological methods 1992;152(1):89-104.
1992: Shin S U; Wei C F; Amin A R; Thorbecke G J; Morrison S L
Structural and functional properties of mouse-human chimeric IgD.
Human antibodies and hybridomas 1992;3(2):65-74.
1992: Bonagura V R; Artandi S E; Agostino N; Tao M H; Morrison S L
Mapping rheumatoid factor binding sites using genetically engineered, chimeric IgG antibodies.
DNA and cell biology 1992;11(3):245-52.
1992: Hastings A; Morrison S L; Kanda S; Saxton R E; Irie R F
Production and characterization of a murine/human chimeric anti-idiotype antibody that mimics ganglioside.
Cancer research 1992;52(7):1681-6.
1992: Ward S B; Morrison S L
Sequence of the gamma 2b membrane 3' untranslated region: polya site determination and comparison to the gamma 2a membrane 3' untranslated region.
Molecular immunology 1992;29(2):279-85.
1992: Artandi S E; Calame K L; Morrison S L; Bonagura V R
Monoclonal IgM rheumatoid factors bind IgG at a discontinuous epitope comprised of amino acid loops from heavy-chain constant-region domains 2 and 3.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(1):94-8.
1992: Wright A; Shin S U; Morrison S L
Genetically engineered antibodies: progress and prospects.
Critical reviews in immunology 1992;12(3-4):125-68.
1991: Anderson M T; Wims L A; Morrison S L
The plasmacytoma J558L lacks constitutively active NF-kappa B and is deficient in early response gene activation.
Nucleic acids research 1991;19(25):7235-41.
1991: Ward S B; Morrison S L
Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection.
Nucleic acids research 1991;19(23):6475-80.
1991: Harrold S; Genovese C; Kobrin B; Morrison S L; Milcarek C
A comparison of apparent mRNA half-life using kinetic labeling techniques vs decay following administration of transcriptional inhibitors.
Analytical biochemistry 1991;198(1):19-29.
1991: Wright A; Tao M H; Kabat E A; Morrison S L
Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure.
The EMBO journal 1991;10(10):2717-23.
1991: Canfield S M; Morrison S L
The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region.
The Journal of experimental medicine 1991;173(6):1483-91.
1991: Tao M H; Canfield S M; Morrison S L
The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain.
The Journal of experimental medicine 1991;173(4):1025-8.
1991: Perfetti V; Borden P; Tao M H; Morrison S L; Kabat E A
Specificity and variable region cDNA sequence of an isogeneic monoclonal antiidiotype to an anti-alpha(1----6)dextran.
Molecular immunology 1991;28(4-5):505-15.
1991: Artandi S E; Canfield S M; Tao M H; Calame K L; Morrison S L; Bonagura V R
Molecular analysis of IgM rheumatoid factor binding to chimeric IgG.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(2):603-10.
1990: Klein B Y; Morrison S L
Expression of genes containing the IgH enhancer in non-lymphoid cells.
Molecular immunology 1990;27(8):713-22.
1990: Shin S U; Morrison S L
Expression and characterization of an antibody binding specificity joined to insulin-like growth factor 1: potential applications for cellular targeting.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(14):5322-6.
1990: Black A; Padlan E A; Givol D; Morrison S L; Kabat E A
Two Ig framework I epitopic specificities recognized by a rabbit antiserum and a monoclonal antibody to mouse VH chains.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(7):2620-6.
1990: Black A; Kabat E A; Morrison S L
Rabbit antisera to the variable region domains of an anti-alpha(1----6) dextran using E. coli-produced VL and VH fusion proteins as immunogens.
Journal of immunological methods 1990;127(1):123-30.
1990: Tan L K; Shopes R J; Oi V T; Morrison S L
Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(1):162-6.
1989: Morrison S L
Genetically engineered (chimeric) antibodies.
Hospital practice (Office ed.) 1989;24(10):65-9, 72-4, 77-80.
1989: Tao M H; Morrison S L
Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(8):2595-601.
1989: Brown S L; Morrison S L
Developmental regulation of membrane and secretory Ig gamma 2b mRNA.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(6):2072-80.
1989: Brown S L; Morrison S L
Regulation of the production of secretory and membrane immunoglobulin during lymphocyte development.
Clinical immunology and immunopathology 1989;50(2):155-70.
1989: Wallick S C; Kabat E A; Morrison S L
The effect of isotype and the J kappa region on antigen binding and idiotype expression by antibodies binding alpha (1----6) dextran.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(4):1235-44.
1989: Sikder S K; Borden P; Gruezo F; Akolkar P N; Bhattacharya S B; Morrison S L; Kabat E A
Amino acid substitutions in VH CDR2 change the idiotype but not the antigen-binding of monoclonal antibodies to alpha(1----6)dextrans.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(3):888-93.
1989: Morrison S L; Oi V T
Genetically engineered antibody molecules.
Advances in immunology 1989;44():65-92.
1988: Morrison S L; Canfield S; Porter S; Tan L K; Tao M H; Wims L A
Production and characterization of genetically engineered antibody molecules.
Clinical chemistry 1988;34(9):1668-75.
1988: Wallick S C; Kabat E A; Morrison S L
Glycosylation of a VH residue of a monoclonal antibody against alpha (1----6) dextran increases its affinity for antigen.
The Journal of experimental medicine 1988;168(3):1099-109.
1988: Gregor P D; Morrison S L
The IgA myeloma W3129 contains a deletion in CH3 which prevents the formation of the membrane form of heavy chain mRNA.
Molecular immunology 1988;25(5):495-503.
1988: Kobrin B; Glass K; Morrison S L; Milcarek C
An immunoglobulin heavy chain gene deletion at direct repeats: nucleotide sequence and effect on mRNA accumulation.
Molecular immunology 1988;25(2):181-7.
1988: Morrison S L; Wims L A; Oi V T
Genetically engineered antibody molecules: new tools for cancer therapy.
Cancer investigation 1988;6(2):185-92.
1987: Akolkar P N; Sikder S K; Bhattacharya S B; Liao J; Gruezo F; Morrison S L; Kabat E A
Different VL and VH germ-line genes are used to produce similar combining sites with specificity for alpha(1----6)dextrans.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(12):4472-9.
1987: Morrison S L; Wims L; Wallick S; Tan L; Oi V T
Genetically engineered antibody molecules and their application.
Annals of the New York Academy of Sciences 1987;507():187-98.
1986: Kobrin B J; Milcarek C; Morrison S L
Sequences near the 3' secretion-specific polyadenylation site influence levels of secretion-specific and membrane-specific IgG2b mRNA in myeloma cells.
Molecular and cellular biology 1986;6(5):1687-97.
1986: Morrison S L; Wims L A; Kobrin B; Oi V T
Production of novel immunoglobulin molecules by gene transfection.
The Mount Sinai journal of medicine, New York 1986;53(3):175-80.
1986: Gregor P D; Kobrin B J; Milcarek C; Morrison S L
Sequences 3' of immunoglobulin heavy chain genes influence their expression.
Immunological reviews 1986;89():31-48.
1985: Sikder S K; Akolkar P N; Kaladas P M; Morrison S L; Kabat E A
Sequences of variable regions of hybridoma antibodies to alpha (1----6) dextran in BALB/c and C57BL/6 mice.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(6):4215-21.
1985: Tan L K; Oi V T; Morrison S L
A human-mouse chimeric immunoglobulin gene with a human variable region is expressed in mouse myeloma cells.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(5):3564-7.

Sign-in to see more